| Primary |
| Infertility |
27.3% |
| Ovulation Induction |
23.9% |
| Drug Use For Unknown Indication |
9.1% |
| In Vitro Fertilisation |
5.7% |
| Infertility Female |
5.7% |
| Maternal Exposure Timing Unspecified |
4.5% |
| Foetal Exposure Timing Unspecified |
3.4% |
| Angina Pectoris |
2.3% |
| Infertility Tests |
2.3% |
| Meniere's Disease |
2.3% |
| Muscle Mass |
2.3% |
| Polycystic Ovaries |
2.3% |
| Alloimmunisation |
1.1% |
| Anovulatory Cycle |
1.1% |
| Artificial Insemination By Partner |
1.1% |
| Basal Cell Carcinoma |
1.1% |
| Blood Testosterone Decreased |
1.1% |
| Estrogen |
1.1% |
| Gestational Diabetes |
1.1% |
| Glaucoma |
1.1% |
|
| Premature Baby |
23.3% |
| Vision Blurred |
10.0% |
| Drug Exposure During Pregnancy |
8.3% |
| Visual Disturbance |
8.3% |
| Abortion Spontaneous |
6.7% |
| Cerebrovascular Accident |
3.3% |
| Congenital Anomaly |
3.3% |
| Craniosynostosis |
3.3% |
| Exposure During Pregnancy |
3.3% |
| Limb Hypoplasia Congenital |
3.3% |
| Maternal Exposure During Pregnancy |
3.3% |
| Mydriasis |
3.3% |
| Ovarian Hyperstimulation Syndrome |
3.3% |
| Pain |
3.3% |
| Visual Impairment |
3.3% |
| Vitreous Floaters |
3.3% |
| Acute Psychosis |
1.7% |
| Alopecia |
1.7% |
| Anaphylactic Reaction |
1.7% |
| Anovulatory Cycle |
1.7% |
|
| Secondary |
| Drug Exposure During Pregnancy |
15.5% |
| Infertility |
14.9% |
| Ovulation Induction |
11.5% |
| In Vitro Fertilisation |
10.9% |
| Anovulatory Cycle |
5.7% |
| Infertility Female |
5.2% |
| Product Used For Unknown Indication |
5.2% |
| Artificial Insemination By Partner |
3.4% |
| Assisted Fertilisation |
3.4% |
| Drug Use For Unknown Indication |
2.9% |
| Foetal Exposure During Pregnancy |
2.9% |
| Polycystic Ovaries |
2.9% |
| Escherichia Infection |
2.3% |
| Hormone Replacement Therapy |
2.3% |
| Ill-defined Disorder |
2.3% |
| Pruritus |
2.3% |
| Hormone Therapy |
1.7% |
| Migraine |
1.7% |
| Vomiting |
1.7% |
| Amenorrhoea |
1.1% |
|
| Breast Cancer Female |
8.9% |
| Drug Withdrawal Syndrome Neonatal |
8.9% |
| Premature Baby |
7.1% |
| Twin Pregnancy |
7.1% |
| Uterine Dilation And Curettage |
7.1% |
| Exomphalos |
5.4% |
| Foetal Exposure During Pregnancy |
5.4% |
| Ruptured Ectopic Pregnancy |
5.4% |
| Systemic Lupus Erythematosus |
5.4% |
| Visual Disturbance |
5.4% |
| Abortion Spontaneous |
3.6% |
| Drug Ineffective |
3.6% |
| Exposure During Pregnancy |
3.6% |
| Maternal Drugs Affecting Foetus |
3.6% |
| Myocardial Infarction |
3.6% |
| Ovarian Cyst |
3.6% |
| Palpitations |
3.6% |
| Uterine Leiomyoma |
3.6% |
| Visual Impairment |
3.6% |
| Abdominal Pain Lower |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.5% |
| Anovulatory Cycle |
15.9% |
| Depression |
7.3% |
| Infertility |
6.8% |
| Rheumatoid Arthritis |
6.1% |
| Off Label Use |
4.5% |
| In Vitro Fertilisation |
4.3% |
| Crohn's Disease |
4.1% |
| Anxiety |
3.9% |
| Polycystic Ovaries |
3.9% |
| Restless Legs Syndrome |
3.6% |
| Ovulation Induction |
3.2% |
| Asthma |
2.9% |
| Acromegaly |
2.7% |
| Contraception |
2.3% |
| Psoriasis |
2.0% |
| Acne |
1.8% |
| Epilepsy |
1.8% |
| Premature Labour |
1.8% |
| Pneumonia |
1.6% |
|
| Drug Exposure During Pregnancy |
12.3% |
| Retinal Vein Occlusion |
11.3% |
| Abortion Spontaneous |
10.4% |
| Pregnancy |
8.5% |
| Retinal Artery Occlusion |
4.7% |
| Stillbirth |
4.7% |
| Vomiting |
4.7% |
| Wound Infection |
4.7% |
| Intra-uterine Death |
3.8% |
| Pain |
3.8% |
| Positional Plagiocephaly |
3.8% |
| Premature Baby |
3.8% |
| Suicidal Ideation |
3.8% |
| Thrombocytopenia |
3.8% |
| Headache |
2.8% |
| Malaise |
2.8% |
| Pancreatitis Acute |
2.8% |
| Ventricular Septal Defect |
2.8% |
| Vomiting In Pregnancy |
2.8% |
| Abdominal Pain |
1.9% |
|
